Skip to Content

Florvio 2.3% Concentrate Solution

This page contains information on Florvio 2.3% Concentrate Solution for veterinary use.
The information provided typically includes the following:
  • Florvio 2.3% Concentrate Solution Indications
  • Warnings and cautions for Florvio 2.3% Concentrate Solution
  • Direction and dosage information for Florvio 2.3% Concentrate Solution

Florvio 2.3% Concentrate Solution

This treatment applies to the following species:
Manufacturer: Elanco (Farm Animal)

(FLORFENICOL) An Antimicrobial

2.3% Concentrate Solution

For Oral Use in Swine Drinking Water Only.

For Use in Animals Only

Florvio 2.3% Concentrate Solution Caution

Federal (USA) law restricts this drug to use by or on the order of a licensed veterinarian.

ANADA #200-519, Approved by FDA.

Description

Florfenicol (Oral Concentrate) is a synthetic broad-spectrum antibiotic. Each milliliter (mL) of Florvio™ 2.3% Concentrate Solution contains 23 mg florfenicol.

Florvio 2.3% Concentrate Solution Indications

Florvio™ 2.3% Concentrate Solution is indicated for the treatment of swine respiratory disease associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis, and Streptococcus suis in swine.

Dosage and Administration

For Proportioner: To produce drinking water with a final concentration of 400 mg/gallon (100 ppm): Fill the bottle of Florvio™ 2.3% Concentrate Solution with water to the fill line. (The Fill line is: 4 liters volume for the 2.17 liter product bottle). Add the contents of the bottle to the mixing tank. Mix thoroughly. Confirm that the proportioner is set to deliver 1:128 (0.8%). Turn on the proportioner. Verify that the drinkers are operational.

For Bulk Tank: To produce drinking water with a final concentration of 400 mg/gallon (100 ppm): Add the Florvio™ 2.3% Concentrate Solution to the drinking water in the bulk tank. Use one 4L bottle (undiluted) of Florvio™ 2.3% Concentrate Solution for every 125 gallons of water.

The medicated water should be administered as the only source of drinking water for five (5) consecutive days. Medication should be initiated promptly when swine respiratory disease is diagnosed.

Precautions

Do not use this product at any other proportioner setting. This will result in precipitation of product. This product is not recommended for use in automatic water proportioners if water hardness is greater than 275 ppm. Water proportioners should be tested for accuracy before use. Do not use or store this product in galvanized metal watering systems or containers. Do not operate chlorinators while administering medication.

RESIDUE WARNINGS: Swine intended for human consumption must not be slaughtered within 16 days of the last treatment. Use of this product in a manner other than indicated or with dosages in excess of those included on the label may result in illegal drug residues in edible tissues.

WARNINGS: NOT FOR HUMAN USE. KEEP OUT OF REACH OF CHILDREN. This product contains material that can be irritating to skin and eyes. Avoid direct contact with skin, eyes, and clothes. In case of accidental eye exposure, flush with water for 15 minutes. In case of accidental skin exposure, wash with soap and water. Remove contaminated clothing. Consult a physician if irritation persists. The Material Safety Data Sheet (MSDS) contains more detailed occupational safety information.

For customer service and/or a copy of the MSDS, call 1-800-843-3386.

For adverse effects reporting, call 1-800-843-3386.

PRECAUTION: The effects of florfenicol on swine reproductive performance, pregnancy, and lactation have not been determined. Do not use in swine intended for breeding.

Adverse Reactions

Perianal inflammation may occur transiently following treatment.

Clinical Pharmacology

Florfenicol is a bacteriostatic agent whose antimicrobial activity is linked to time above MIC.

The pharmacokinetic disposition of florfenicol was evaluated in swine following oral gavage dosing (15 mg/kg), intravenous (IV) dosing (15 mg/kg), and during a five (5) day course of ad libitum administration in drinking water (100 ppm) (Table 1). Despite the rapid elimination seen after IV injection or oral gavage dosing, when administered in medicated drinking water, florfenicol concentrations in the serum of most swine were maintained well above 1.0 mcg/mL for the majority of the five (5) day dosing interval. These results are consistent with product effectiveness when administered in drinking water concentrations of 100 ppm over a five (5) day dosing period.

Although the extent of oral drug absorption (F) tended to be variable (24% to 97% following a single oral gavage dose), florfenicol was rapidly absorbed. Its terminal elimination half-life (T1/2) was also rapid, ranging between two (2) to three (3) hours. The average systemic clearance (CLB) following IV administration was 5.6 mL/kg/min. Since the florfenicol steady state volume of distribution (VDSS) closely approximates that of total body water, peripheral tissue concentrations are expected to be similar to those concentrations observed in serum.

Table 1. Pharmacokinetic Parameter Values of Florfenicol following IV or Gavage Dosing

Parameter

Median Value (%CV)

VdSSa (L/kg)

0.95 (6)

CLBa (mL/kg/min)

5.57 (11)

T1/2a (hrs)

2.2 (14)

Fb (%)

24-97

aparameter estimate based on intravenous data

bparameter range based upon a single oral gavage dose

MICROBIOLOGY: Florfenicol is a synthetic broad-spectrum antibiotic active against many gram-negative and gram-positive bacteria isolated from domestic animals. It acts by inhibiting bacterial protein synthesis. In vivo and in vitro activity has been demonstrated against commonly isolated pathogens involved in swine respiratory disease including Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella choleraesuis, and Streptococcus suis.

The minimum inhibitory concentration (MIC) of florfenicol was determined for isolates obtained from natural respiratory infections of swine from 1990-2001 (Table 2). Susceptibility testing followed the methods of the National Committee of Clinical Laboratory Standards. Reference strains included Escherichia coli ATCC 25922 with a QC range of 2-8 mcg/mL and Actinobacillus pleuropneumoniae ATCC 27090 with a QC range of 0.25-1 mcg/mL.

Table 2. MIC Values of Florfenicol Against Bacterial Isolates from Swine

Table 2. MIC Values of Florfenicol Against Bacterial Isolates from Swine

Organism

Isolate Numbers

MIC90** (mcg/mL)

MIC Range (mcg/mL)

Actinobacillus pleuropneumoniae

360

0.50

≤0.125-2.0

Pasteurella multocida

335

0.50

≤0.125-2.0

Salmonella choleraesuis

46

4.0

2.0-4.0

Streptococcus suis

203

2.0

0.5-2.0

*The minimum inhibitory concentration for 90% of the isolates

ANIMAL SAFETY: A target animal safety study was conducted to evaluate the tolerance and effects of florfenicol when orally administered to swine via the drinking water at a rate of 400, 1200, and 2000 mg/gal (1x, 3x, or 5x the clinical dose) for fifteen (15) to sixteen (16) consecutive days (3x the clinical duration), and at 4000 mg/gal (10x clinical dose) for five (5) to six (6) consecutive days (1x the clinical duration). Transient treatment-related constipation and anal swelling were seen in the 3x, 5x, and 10x treatment groups. The constipation in these groups was attributed in part to decreased water consumption during the medication period. There was a decrease in weight gains for the 3x, 5x, and 10x treatment groups compared with the nonmedicated control group.

Transient treatment-related decreases in water consumption were noted in all test article-treated groups (1x, 3x, 5x, and 10x) compared with the nonmedicated control group.

The results show that florfenicol can be safely administered to swine according to the recommended clinical regimen of 400 mg/gal in the drinking water for five (5) consecutive days.

STORAGE CONDITIONS: Store between 2° - 25°C (36° - 77°F).

How Supplied

Florvio™ 2.3% Concentrate Solution is supplied in 4 liter plastic bottles containing 2.17 liter of solution, respectively.

Novartis Animal Health US, Inc., 3200 Northline Avenue., Suite 300, Greensboro, NC 27408 U.S.A.

Made in United Kingdom.

Florvio™ is a trademark of Novartis AG, Basel

Copyright © 2012, Novartis Animal Health US, Inc., Greensboro, NC 27408.

All rights reserved.

Rev. date: 04/14

615545 USA 311496

 

Product #

 

2.17 Liters

613117

NAH/FLO/23mg/4L-LB/2

NAC No.: 1114117.1

ELANCO US, INC.
Distributed by ELANCO ANIMAL HEALTH
2500 INNOVATION WAY, GREENFIELD, IN, 46140
Main Switchboard:   317-433-4800
Customer Service:   317-276-1262
Small Animal Product Customer Service:   888-545-5973
Technical Services:   800-428-4441
Fax:   317-276-2270
Website:   www.elanco.com
Email:   elanco@elanco.com
Every effort has been made to ensure the accuracy of the Florvio 2.3% Concentrate Solution information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.

Copyright © 2016 North American Compendiums. Updated: 2016-08-21

Hide